Whereas PBS‐treated recipients had severe GVHD in the skin, intestine, liver and lung, ADAMTS13‐treated mice exhibited only mild changes in these organs (Figure 1B) and significantly lower GVHD scores (Figure 1C). Here, ADAMTS13 is linked to graft versus host disease.